Wealth Destroyers as Potential Multibaggers~ Mumbai Equity Workshop Sat June 17 2017

Wealth Destroyers as Potential Multibaggers~ Announcing a Full Day Mumbai Fundamental Equity Workshop on Saturday, June 17 2017 

🙂 This time in this Stock Selection ~Value Vs Price Workshop have kept an exciting Theme :

WEALTH DESTROYERS : POTENTIAL MULTIGAGGERS

As Limited Seats would advice to Book Your Seat right away here => http://www.jsalphaa.com/register.php

Plan to cover over 25 Wealth Destroyers to assess any Turnaround Value vs Price & thus a chance to redeem themselves and become Wealth Creators from here… or should just one move on in many of such Wealth Destroyers that are now beyond redemption

read more

Exciting iPSC Stem Cell Technology~Autologous & Allogeneic

This Morning  this brief news release on breakthroughs in Stem Cell Research caught my attention

It also added two words to my vocabulary ~ Autologous & Allogeneic in this regenerative medicine space

The Japanese Shinya Yamanaka who won the 2012 Nobel Prize for his research on stem cells has created a new exciting approach termed as iPSC Technology…that’s induced Pluripotent Stem Cells

Any human cell can be genetically reprogrammed to an embryonic state

In US there have been ethical concerns on the use of embryonic stem cells .However,Yamanaka’s research allows for the use of adult cells 

read more

Opprobrium~Harsh Censure~ Charlie Munger thrashes Valeant Pharma calling it a sewer

Warren Buffett and Charlie Munger

Came across the use of Opprobrium in context of the shaming the conduct of  Valeant Pharmaceuticals, once the darling of Wall Street

It stands for Harsh Criticism or Censure or public disgrace for shameful conduct…. Valeant has been accused of Price gouging, secret network of speciality pharmacies & fraud  

Always loved the Bluntness of Charlie Munger ,Vice Chairman of Berkshire Hathaway.He’s 92 now and his words carry huge weight

Yesterday at BH’s AGM in Omaha,both Warren Buffett & he took on pre-selected questions for several hours.This Q & A is one of the most awaited sessions at the AGM

read more

A Dose of Rakesh Jhunjhunwala

Rakesh Jhunjhunwala on Future of Equity Market

Methinks every Indian Equity Investor needs a dose of Rakesh Jhunjhunwala (RJ) every few years! ~ any sooner it could be an Overdose !  😆 ~ just kidding !

I like the guy ! ~ right since I interacted with him when I invited him around 15 years ago at the turn of this century for interacting in an evening  Q & A session with my packed class of @ 90 participants in my Equity Portfolio Structuring and Stock Analysis Workshop at the BSE Training Institute as I thought he would add practical value & he did

read more

Sensex disappoints in FY 16 as many of the 30 constituents lose big value

FY 16 has been a mixed year for Stocks with Markets on a downward drift  with  Sensex closing 9.4% lower  at 25341

Sensex disappoints in FY 16 as many of the 30 constituents lose big value 

Interesting & Heartening to it’s Shareholders ,Reliance has been the biggest constituent gainer at @ 27% while at the other end BHEL has lost half it’s value at 51% !  ~ another 11 companies have lost between @ 19% to 30 % values

Domestic Concerns revolved around  second consecutive failure of monsoon in 2015 &  slow pace of Reforms  & Corporate Earnings Lethargy with growth in single digits despite boasts of GDP Growth of over 7% and lower Inflation and Oil Price falling 40%

read more

Warning !!! ~ Caution on Sang Froid Labs at BSE Upper Circuit Rs 8.71 !

Warning !!! ~ Caution on Sang Froid Labs at BSE Upper Circuit Rs 8.71 !

How can BSE even have allowed Sang Froid to be directly listed from October 2015 ! ?

Bulk Trades ~ Lakhs of  Shares Trading Volume ~ Buy Reco being circulated under Share Khan Premium Service  with website as sharkhan.in  which just flashes on your screen repeatedly!!!

PLEASE STAY AWAY FROM SANG FROID LABS

SEBI must investigate how BSE allowed this Listing & the trading patterns in it….Wonder if  the Broking Group Sharekhan  & Pharma Co Ajanta Pharma will ignore that their names have been misused liked this for recommending Sang Froid…..I don’t believe Sharekhan has recommended this….& I dont believe Ajanta Pharma is associated with this company in any way let alone it being recommended as a Venture with it !   

read more